Showing posts with label children. Show all posts
Showing posts with label children. Show all posts

Monday, July 18, 2011

Children 'risk sunburn at school'

15 July 2011 Last updated at 00:30 GMT By Michelle Roberts Health reporter, BBC News school children Young skin is sensitive to the sun's strong rays All UK schools should be required to have a comprehensive sun safety policy to protect children from skin cancer, a charity campaigner says.

A recent survey of 1,000 parents, commissioned by MPs on the All-Party Parliamentary Group on Skin, found almost 40% of pupils have suffered sunburn while at school.

Richard Clifford of Skin Cancer UK says this is "entirely unacceptable" and wants mandatory sun rules for schools.

Current guidelines are not compulsory.

The call comes as parents of a 10-year-old girl who attends a school near Swansea complained their daughter had suffered severe sunburn at a sports day.

Pennard Primary School said parents could come in at lunch-time to apply cream, but that it would be impossible for teachers to apply suncream to the 200 children attending the school.

Advice from the National Institute for Health and Clinical Excellence (NICE) says schools should encourage children to seek shade whenever possible, particularly when out playing in the midday sun.

And it says sunscreen (of at least SPF 15 strength) should be applied liberally half an hour before and after going out in the sun and reapplied every two hours thereafter.

Child safety

Nurseries and pre-schools have higher staff-child ratios to deal with such demands.

But what is not clear is exactly how schools are expected to deliver this.

Mr Clifford said: "Admittedly teachers cannot be expected to apply sunscreen due to simple time pressures.

Continue reading the main story
Children have delicate skin and getting sunburnt as a child increases the risk of skin cancer later in life”

End Quote Dr Claire Knight of Cancer Research UK "There is also the inevitable question regarding their concerns over child abuse and the strong advice they receive from local authority education departments and trade unions.

"However, there is no reason whatsoever why they should not supervise the application, perhaps with the assistance of the school nurse or indeed parents who attend on a pre-arranged rota system."

NICE suggests parents could provide sunscreen for their children who could, in turn, be taught how to apply it for themselves and their school-friends.

The guidelines also recommend schools run awareness campaigns to alert children to the harms of too much sun exposure.

But Mr Clifford says in reality too few do.

"Instead, it is left to the individual teacher to decide as to whether or not to introduce the subject of UV awareness. This is simply not good enough."

Over-exposure

Cancer Research UK has produced information to help schools develop a sun safe policy, but so far only 621 English primary schools have registered to receive this sun protection policy pack.

Dr Claire Knight, health information officer at Cancer Research UK, said: "It's important that children are protected from sunburn while at school.

"Children have delicate skin and getting sunburnt as a child increases the risk of skin cancer later in life."

Prolonged over-exposure to the sun and episodes of sunburn under the age of 15 are major risk factors for skin cancer in later life.

The British Association of Dermatology estimates that four out of five skin cancer deaths are preventable.

Dr Knight said: "Cancer Research UK encourages schools to develop their own sun protection policy, and recommends that children should be allowed to bring sunscreen of at least SPF 15 with four or five stars into school and be supervised whilst applying it.

"Using shade and clothing is also crucial to any policy designed to promote the safe enjoyment of the sun."


View the original article here

Thursday, May 19, 2011

Sickle cell drug 'helps children'

13 May 2011 Last updated at 04:27 GMT Sickle and normal blood cells Drugs cans be used to alleviate the symptoms of sickle cell even in young children, researchers say. A drug to treat sickle cell anaemia is safe for use in children and should be made available, US doctors say.

Sickle shaped red blood cells are more likely to block blood vessels and die sooner, resulting in pain, organ damage and early death.

The study in the Lancet, involving some 200 US babies, found hydroxycarbamide reduced pain and other complications in the half given the drug.

A UK expert said the findings were "extremely encouraging".

Hydroxycarbamide is already available for use in adults, but its effectiveness had not been tested in young children.

Major effect

In the study, the babies taking the drug had half the number of painful events - pain lasting more than two hours and needing drug treatment.

There was an 80% reduction in cases of pain and tenderness in the hands and feet (dactylitis).

Continue reading the main story
The success of this trial in early infancy is particularly encouraging”

End Quote Professor David Weatherall University of Oxford The study says the only negative effect was mild or moderate neutropenia, in which the number of infection fighting white blood cells falls.

The researchers said the study "should have a major effect on guidelines for the management of children with sickle cell anaemia.

"Hydroxycarbamide therapy can now be considered for all very young children with sickle cell anaemia."

Organ damage

David Rees, a consultant paediatric haematologist and medical adviser to the Sickle Cell Society, said that while it was "encouraging" that the drug was safe in very young children" the study was "in a way disappointing".

He said the primary goals of the study had been to show an impact on spleen or kidney function as "it had been hoped that if you can intervene early you could prevent organ damage", yet this was not the case.

Professor David Weatherall, from the University of Oxford, said: "These findings are extremely encouraging.

"Hydroxycarbamide is inexpensive and could certainly be made available in low-income countries in which sickle-cell anaemia is so common."

"In view of the early deaths that result from this disease in sub-Saharan Africa, the success of this trial in early infancy is particularly encouraging."


View the original article here